Alterations in homologous recombination repair genes in prostate

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial - The Lancet Oncology

Improving Patient Access to Homologous Recombination Deficiency Testing for Precision Oncology

HRR Gene Alterations in Prostate Cancer

The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment

Cancers, Free Full-Text

Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification - Xentech

The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies - Rimar - 2017 - Cancer - Wiley Online Library

DNA Damage Repair Deficiency in Prostate Cancer: Trends in Cancer

Alterations in homologous recombination repair genes in prostate cancer brain metastases

Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage